Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tim A Labeur

ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 4

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Acta oncologica (Stockholm, Sweden)

University of Amsterdam (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Amsterdam Aug 31o 2009 - Jun 1o 2016

Netherlands

MSC

Publications

Tim A Labeur, Quincy Hofsink, R Bart Takkenberg, Otto M van Delden, Ron A A Mathôt, Regina Schinner, Peter Malfertheiner, Holger Amthauer, Kerstin Schütte, Bristi Basu, Christiane Kuhl, Julia Mayerle, Jens Ricke, Heinz-Josef Klümpen
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial. Acta oncologica (Stockholm, Sweden) 59 (9) (2020)
Tim A Labeur, Sarah Berhane, Philip James Johnson
Response to: Prognostication of HCC patients under sorafenib is not always possible. Liver international : official journal of the International Association for the Study of the Liver 40 (5) (2020)
Tim A Labeur, Sarah Berhane, Julien Edeline, Jean-Frederic Blanc, Dominic Bettinger, Tim Meyer, Jeroen L A Van Vugt, David W G Ten Cate, Robert A De Man, Ferry A L M Eskens, Alessandro Cucchetti, Laura Jayne Bonnett, Otto M van Delden, Heinz-Josef Klümpen, R Bart Takkenberg, Philip J Johnson
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Tim A Labeur, David W G Ten Cate, R Bart Takkenberg, Hicham Azahaf, Martijn G H van Oijen, Otto M van Delden, Robert A de Man, Jeroen L A van Vugt, Jan Nicolaas Maria IJzermans, Ferry A L M Eskens, Heinz-Josef Klümpen
Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma. Acta oncologica (Stockholm, Sweden) 57 (11) (2018)

Tim A Labeur.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tim A Labeur